EUR/USD: Brighter vaccination prospects in Europe to limit the downside – MUFG
|Vaccination roll-out in key EU countries surges, improving the outlook for the EUR/USD pair, DerekHalpenny, Head of Research, Global Markets EMEA & International Securities at MUFG Bank, reports.
See – EUR/USD: Strong US economic data to cause another leg lower – Rabobank
Tentative turn in infections in key EU countries
“Former French Finance Minister and EU vaccine coordinator, Thierry Breton confirmed an ‘extremely rapid increase’ in vaccine production in the EU that leaves the EU on track for vaccinating 70% of adults by July. That appears a long shot at this stage but levels between 50% and 60% remain feasible.”
“The infection rates in France, Italy and Germany are providing some relief that the current wave may be easing. The 7-day averages in Germany and France have eased off in April – infections have eased more notably in Italy.”
“The higher yields in the US and the evidence of better COVID-19 vaccination roll-outs in Europe may well limit EUR/USD downside if we do see the US dollar bid following higher inflation leading to higher yields. We’d still expect a EUR/USD decline but the euro should outperform other G10 currencies versus the dollar.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.